The significant EPS miss and lack of positive guidance suggest near-term downside risk. Traders should monitor for any analyst downgrades or revised price targets, and watch for the Q2 2026 earnings release on August 6, 2026, for signs of recovery or further deterioration.
Price Chart
Executive Summary
Omada Health reported Q1 2026 EPS of -$0.05, a 181.6% miss vs consensus of $0.06, marking a significant earnings disappointment. Revenue of $80.1M matched estimates, but the EPS miss and lack of raised guidance signal operational challenges. The stock may face downward pressure given the magnitude of the EPS miss and the company's pre-revenue profile.
Key Financial Metrics
Key Facts
- Q1 2026 EPS: -$0.05 vs consensus $0.06 (miss of -181.6%)
- Revenue: $80.1M, in line with consensus of $80.1M
- EPS miss is the largest in the last four quarters, reversing a prior beat trend
- No guidance raised or subscription growth metrics provided in the filing
- Market cap $1.4B with 83% analyst bullishness, but recent insider selling of $456K in 30 days
Financial Impact
EPS miss of -$0.11 per share vs consensus, representing a 181.6% negative surprise
Risk Factors
- EPS miss of 181.6% may trigger negative analyst revisions and selling pressure
- Recent insider selling of $456K in 30 days could indicate management concern
- Pre-revenue profile with negative EPS makes the stock highly sensitive to earnings surprises
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3332379 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | Insider Cluster | $20.50 $20.61 | ▼ −0.54% | ▼ −0.43% | $20.65 (−0.73%) |
Sep 4, 2026 28d ago | Insider Cluster | $22.77 $20.50 | ▲ +9.97% | ▲ +8.76% | $20.65 (+9.31%) |
Sep 3, 2026 28d ago | Insider Cluster | $22.77 $20.50 | ▼ −9.97% | ▼ −8.76% | $20.65 (−9.31%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.84 $24.47 | ▲ +2.64% | ▲ +3.09% | $20.65 (−13.38%) |
Jul 23, 2026 10w ago | Press Release | $21.20 $19.69 | ▲ +7.12% | ▲ +7.60% | $20.65 (+2.59%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.55 $23.67 | ▼ −0.51% | ▼ −0.64% | $20.65 (+12.31%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.55 $23.67 | ▲ +0.51% | ▲ +0.64% | $20.65 (−12.31%) |
Jul 6, 2026 12w ago | Insider Cluster | $22.85 $23.28 | ▼ −1.88% | ▼ −1.39% | $20.65 (+9.63%) |
Jul 6, 2026 12w ago | Insider Cluster | $22.85 $23.28 | ▲ +1.88% | ▲ +1.39% | $20.65 (−9.63%) |
Jul 3, 2026 13w ago | Insider Cluster | $22.39 $23.55 | ▼ −5.18% | ▼ −4.25% | $20.65 (+7.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access